Approval strengthens Akari’s global intellectual property across all major markets and supports advancement of AKTX-101 and ADC pipeline TAMPA, Fla. and LONDON, April 27, 2026 (GLOBE NEWSWIRE) -- ...
GSK has acquired the rights to Syndivia’s preclinical antibody drug conjugate (ADC), which is in development for prostate cancer treatment, fuelling the ongoing industry buzz for the promising ...
The UK pharma giant AstraZeneca will invest $1.5 billion to build its first end-to-end antibody-drug conjugate (ADC) manufacturing facility in Singapore. The plant will be designed to manufacture all ...
New Preclinical Results at AACR 2026 Show Plinabulin Dramatically Improves Complete Response Rates and Survival When Combined with Leading ADC ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results